Why the study?
Does immediate treatment with propranolol or atenolol reduce mortality in patients with suspected acute myocardial infarction?
Does immediate treatment with propranolol or atenolol reduce mortality in patients with suspected acute myocardial infarction?
Immediate administration of propranolol or atenolol did not significantly reduce one-year mortality compared to placebo in patients with suspected acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Immediate beta-blockers lack mortality benefit in suspected acute MI; challenges routine early use and supports selective application in future trials.
The value of beta-blockade for suspected acute myocardial infarction was assessed by determining the six-week and one-year mortality rates in patients started on propranolol, atenolol, or placebo immediately on entry to a coronary care unit. A total of 388 patients entered this double-blind, randomised study, and when analysed on the basis of the initial, intention-to-treat categories there was no significant difference between the three groups in respect of the mortality rate at one year. There was, however, a high withdrawal rate from the trial; the reasons for this illustrate problems of physician compliance and interpretation of data, which are common to all early-entry trials of haemodynamically active agents in acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Roland et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: